Sangamo to put ‘substantially all’ assets for sale in bankruptcy, lines up Lilly and Astellas as buyers

Velocity timeline

How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →

Coverage (8)

• Sangamo Therapeutics, Inc. Filed for Bankruptcy marketscreener.com · 11h ago
• Lilly, Astellas bid on Sangamo's assets after bankruptcy filing FirstWord Pharma · 11h ago
• Sangamo Therapeutics files for bankruptcy as Lilly and Astellas split assets The Business Journals · 11h ago
• Sangamo Therapeutics Files for Chapter 11 Bankruptcy Protection citybiz · 11h ago
• Gene Therapy Developer Sangamo Hits Ch. 11 With Sale Plans Law360 · 11h ago
• Sangamo Therapeutics Sets Stalking Horse Sales: $50M to Eli Lilly, Up to $50M to Astellas TradingView · 11h ago
• UPDATE: Lilly, Astellas circle Sangamo assets as biotech files for bankruptcy BioSpace · 11h ago
• Sangamo to put ‘substantially all’ assets for sale in bankruptcy, lines up Lilly and Astellas as buyers Fierce Biotech · 11h ago broke it first

Related trends